Department of Rheumatology, Erasmus MC, Rotterdam.
Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands.
Rheumatology (Oxford). 2022 May 30;61(6):2583-2589. doi: 10.1093/rheumatology/keab793.
We investigated whether work participation is affected in patients with arthralgia during transition to RA. Arthralgia patients with symptom resolution and early RA patients at diagnosis were used as a reference.
Three groups of patients were studied: arthralgia patients converting to RA (n = 114), arthralgia patients with spontaneous symptom resolution (n = 57), and early RA patients (n = 617). Both presenteeism (i.e. working while sick, scale 0-10) and absenteeism (i.e. sick leave) were taken into account. Work ability 1 year prior to clinical arthritis was estimated (in absolute numbers). The course of work restriction over time was studied using linear mixed models (β coefficient; delta per month) within each patient group.
One-year prior to the development of clinical arthritis, mean presenteeism was 7.0 (95% CI 5.8, 8.1) in patients with arthralgia, indicating 30% loss, and further worsened to 6.1 (95% CI 5.3, 6.6) at RA diagnosis, thus indicating 39% loss. In early RA patients, presenteeism improved over time after DMARD initiation (β 0.052 per month 95% CI 0.042, 0.061, P < 0.0001). Presenteeism also improved in arthralgia patients who achieved spontaneous symptom resolution (β 0.063 per month, 95% CI 0.024, 0.10, P = 0.002). Absenteeism did not change significantly in arthralgia patients, but did improve in RA after DMARD-start. ACPA stratification revealed similar results.
In the months preceding RA, presenteeism was already apparent, and it worsened further during progression to clinical arthritis and diagnosis. This underlines the relevance of the symptomatic pre-RA phase for patients. The observed reversibility in arthralgia patients with symptom resolution may suggest that intervention in pre-RA could improve work participation.
我们研究了在关节炎向 RA 转变过程中,关节痛患者的工作参与情况是否受到影响。以症状缓解的关节痛患者和诊断时的早期 RA 患者为参照。
研究了三组患者:即将发展为 RA 的关节痛患者(n=114)、症状自行缓解的关节痛患者(n=57)和早期 RA 患者(n=617)。同时考虑了现患率(即带病工作,评分 0-10)和缺勤率(即病假)。评估了临床关节炎发病前 1 年的工作能力(绝对值)。在每个患者组内,使用线性混合模型(β系数;每月差值)研究了随时间推移工作受限的情况。
在发展为临床关节炎前 1 年,关节痛患者的现患率平均为 7.0(95%CI 5.8,8.1),表明丧失了 30%的工作能力,在 RA 诊断时进一步恶化至 6.1(95%CI 5.3,6.6),表明丧失了 39%的工作能力。在早期 RA 患者中,DMARD 治疗开始后现患率随时间逐渐改善(β每月增加 0.052,95%CI 0.042,0.061,P<0.0001)。症状自行缓解的关节痛患者的现患率也有所改善(β每月增加 0.063,95%CI 0.024,0.10,P=0.002)。关节痛患者的缺勤率没有明显变化,但在接受 DMARD 治疗后有所改善。ACPA 分层也得到了类似的结果。
在 RA 前的几个月中,现患率已经很明显,在向临床关节炎和诊断进展的过程中进一步恶化。这突显了症状前 RA 阶段对患者的重要性。症状自行缓解的关节痛患者的可逆性表明,在 RA 前进行干预可能会改善工作参与度。